Tuberculosis (TB) — still present in the UK

Tuberculosis is infection with Mycobacterium tuberculosis — most often lungs (pulmonary TB) but can affect any organ (extrapulmonary TB).

UK incidence is low compared globally but concentrated in urban areas and migrant communities from high-prevalence countries. Drug-sensitive TB is curable — treatment requires months of antibiotics and public health support.

Pulmonary TB symptoms

Classic triad:

Also:

  • haemoptysis — blood in sputum
  • fever, fatigue
  • chest pain, breathlessness

Insidious onset — weeks to months — not sudden like pneumonia.

Extrapulmonary TB

SiteFeatures
Lymph nodesPainless neck swelling — scrofula
Spine (Pott disease)Back pain, deformity
Brain (TB meningitis)Headache, meningism — emergency
AbdominalPain, weight loss
GenitourinarySterile pyuria

HIV co-infection — atypical presentation, faster progression — see HIV guide.

Latent vs active

Latent TB infection (LTBI):

  • positive IGRA/Mantoux blood or skin test
  • normal chest X-ray
  • no symptoms
  • not infectious
  • treatment offered if high reactivation risk — immunosuppression, recent conversion

Active TB:

  • symptoms + microbiology (culture, PCR) or strong clinical/radiological evidence
  • notifiable — contact tracing
  • chest X-ray — upper lobe cavitation classic

Diagnosis

  • chest X-ray
  • sputum — auramine stain, culture, GeneXpert MTB/RIF — rapid resistance detection
  • IGRA blood test (interferon-gamma release assay) — latent screening
  • HIV test — all TB patients

Treatment

Standard active pulmonary TB ( drug-sensitive):

  • 6 months combined antibiotics
  • initial 2 months: RIPE — rifampicin, isoniazid, pyrazinamide, ethambutol
  • continuation 4 months: rifampicin + isoniazid

Directly Observed Therapy (DOT) — nurse watches doses — ensures completion.

Side effects:

  • liver toxicity — monitor LFTs
  • orange body fluids — rifampicin
  • neuropathy — isoniazid — pyridoxine co-prescribed

MDR-TB — resistant to rifampicin/isoniazid — specialist centre, longer regimens.

Never stop early — breeds resistance.

Prevention

  • BCG — selected infants/high-risk
  • screening new entrants from high-prevalence countries
  • treat latent TB in immunosuppressed before biologics
  • ventilation in high-risk settings

When urgent

  • massive haemoptysis
  • respiratory failure
  • TB meningitis suspicion — 999
  • MDR-TB — isolation, specialist

TB is slow, treatable, and stigmatised — 3-week cough with weight loss in at-risk groups deserves chest X-ray and sputum, not repeated antibiotics alone.

Common questions about tuberculosis

What are the symptoms of tuberculosis?
Persistent cough over 3 weeks — sometimes blood-streaked sputum, night sweats, weight loss, loss of appetite, fever, fatigue, chest pain. Extrapulmonary TB affects lymph nodes, spine, brain, kidneys — symptoms vary by site. Many latent cases have no symptoms.
How do you catch tuberculosis?
Inhaled droplets from cough or sneeze of person with active pulmonary TB — usually requires prolonged close contact in enclosed spaces — household, prison, some workplaces. Not spread by brief casual contact, plates, or toilet seats. Latent TB is not contagious.
What is the difference between latent and active TB?
Latent — bacteria dormant, no symptoms, not infectious, positive skin or blood test. Active — bacteria multiplying, symptoms, infectious — needs treatment and public health contact tracing. Latent can reactivate to active — especially if immunosuppressed.
How is tuberculosis treated?
Active pulmonary TB — typically 6 months antibiotics — isoniazid, rifampicin, ethambutol, pyrazinamide combination initially, then continuation phase. Directly observed therapy ensures adherence. Latent TB — shorter regimens (e.g. 3 months isoniazid/rifapentine) for those at high reactivation risk.
Is there a vaccine for TB?
BCG vaccine given at birth in areas with high TB rates or to at-risk babies — partial protection against severe childhood TB — not fully protective against adult pulmonary TB. Not part of routine UK schedule in low-incidence areas.
Can TB come back after treatment?
Relapse uncommon if full course completed correctly. Reinfection possible in high-exposure settings. Drug-resistant TB harder to treat — emphasises completing standard treatment first time.

Sources

How we reviewed this page

Medically reviewed by the HealthAnswers UK doctor review panel

First published
Medically reviewed
Next review due
or sooner if NHS or NICE guidance changes

Written by HealthAnswers editorial team. Published by HealthAnswers (Elite Digital AI Solutions Ltd). How we review content · Report a problem with this page